PRCT - Company ID 0001588978
PROCEPT BioRobotics Corp trades as PRCT and has a market capitalization of $1.12 B, making it the #2568 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $308.05M, up 37.2% from the prior year and net income of -$95.57K. This page tracks PROCEPT BioRobotics Corp through 360 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-10
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 5 fiscal years PROCEPT BioRobotics Corp's revenue grew from $7.72M to $308.05M, a compound annual growth rate of 109.0%. Net profit margin expanded from -687.0% to -0.0% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-18 |
| SCHEDULE 13G | - | 2026-04-30 |
| New insider ownership | 3 | 2026-04-30 |
| Quarterly report | 10-Q | 2026-04-30 |
| Major company event | 8-K | 2026-04-29 |
| New insider ownership | 3 | 2026-04-24 |
| Proxy materials | DEFA14A | 2026-04-22 |
| Proxy statement | DEF 14A | 2026-04-22 |
The largest companies sharing PROCEPT BioRobotics Corp's SEC industry classification (surgical & medical instruments & apparatus).
PROCEPT BioRobotics Corp (PRCT) has a market capitalization of $1.12 B as of 2026-07-10, ranking #2568 among US-listed companies.
PROCEPT BioRobotics Corp reported revenue of $308.05M for fiscal year 2025, an increase of 37.2% year over year.
In its latest fiscal year PROCEPT BioRobotics Corp reported a net loss of $95.57K.